Axogen, Inc. Reports Third Quarter 2026 Financial Results

Go back to Axogen, Inc. Reports Third Quarter 2026 Financial Results

AxoGen, Inc. (AXGN) PT Raised to $65 at Mizuho

October 28, 2026 3:25 PM EDT

Mizuho analyst Anthony Petrone raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $65.00 (from $58.00) while maintaining a Outperform rating.

The analyst comments "Key post-call updates from our call with management include: 1) base organic growth of +27% being driven by inflection in Breast along with continued... More